Democratic Republic of Congo Ebola Outbreak Surpasses 11,000 Cases and 5,387 Deaths

The Democratic Republic of Congo is facing its deadliest and fastest-growing Ebola outbreak in history, with total infections surpassing 11,000. According to official government figures released on Wednesday, the virus has infected 11,042 people and claimed 5,387 lives, resulting in a fatality rate of nearly fifty percent. The current public health emergency is the country's 17th recorded outbreak and has spread to eight of the nation's 26 provinces.

Containment Challenges and Armed Conflict

Efforts to control the rapid transmission of the virus have been severely hampered by ongoing armed conflict, healthcare worker strikes, and poor road infrastructure. Key hotspots in Ituri and North Kivu provinces have experienced renewed violence, putting medical personnel at risk and forcing the closure of several response and screening centers. Furthermore, local skepticism, misinformation, and community mistrust have occasionally escalated into hostility toward health workers.

Vaccine Trials and International Response

The outbreak is driven by the Bundibugyo strain of the virus, which currently lacks an approved vaccine or specific medical treatment. Vaccine trials are being organized under the guidance of the country's National Institute for Biomedical Research, with backing from the World Health Organization and international partners. During a 4 November press conference, WHO chief Tedros Adhanom Ghebreyesus emphasized that vaccines alone are insufficient, stressing the ongoing need for early medical care, contact tracing, and community engagement.

Travel Restrictions Adjusted

In response to the broader regional impacts of the public health crisis, the United Arab Emirates modified its travel policies. Authorities lifted a suspension on issuing new visas to Ugandan nationals introduced in June 2026, establishing updated entry requirements that mandate a 21-day period following departure from Uganda, alongside specific exemptions for students, diplomats, and medical travelers.